| inhibition of chemical mediator release from human leukocytes by a new antiasthma drug, hc 20-511 (ketotifen). | | 1979 | 91958 |
| [the enzymatic activity of ammonia metabolism in the liver during the parenteral nitrogen feeding of animals with experimental liver failure]. | it was established that liver insufficiency the activity of hepatic glutamate dehydrogenase is markedly reduced that is, apparently, the main cause of hyperammonemia that accompanies hepatic encephalopathy. here occurs a significant reduction of the processes of ammonia detoxication with formation of glutamine in the liver as evidenced by changes of the activity of glutamine synthetase. administration parenterally of a preparation of nitrous feeding increases essentially ammonia detoxicating fun ... | 1992 | 1413686 |
| [the quantities of dried venom collected from specimens of vipera ammodytes l., 1758 (reptilia, viperidae) in captivity in bulgaria]. | some researches have been made to obtain more data about quantities of dried venom collected from vipera ammodytes l., 1758 in captivity. the minimal quantity of dried venom collected by exemplar is 9.7 mg to 36.4 mg and the maximal quantity is 49.0 mg to 90.3 mg. from 810 exemplars of v. ammodytes of bulgaria and 9 months of investigations, 10597 samples were made, with a total of 298.164 g of dried venom (average for animal: 28.14 mg). | 1985 | 3834856 |
| responses of plasma glucose, free fatty acids and glucagon to cobalt and nickel chlorides by gallus domesticus. | | 1973 | 4148979 |
| the metabolism of phosphatidylinositol in the thyroid gland of the pig. | 1. the metabolism of phosphatidylinositol in pig thyroid has been investigated as a basis for understanding the specific stimulation of the synthesis of this phospholipid in the gland by thyrotropin. 2. the gland contained an active ca(2+)-dependent phosphatidylinositol-splitting enzyme with an optimum ph of 5.3-5.5. 3. the major water-soluble product (65%) formed by this catabolic enzyme was not phosphorylinositol but a related compound, which may be a cyclic phosphorylinositol. both this and p ... | 1971 | 4331518 |
| [demonstration of the relationship between the origins of cherry leaf-roll virus and elm mosaic virus]. | | 1972 | 4628106 |
| changes in plasma lipids and blood glucose concentration of obese patients. | | 1998 | 106137 |
| laboratory recognition of coronary artery disease (with a review of the surgical treatment). | | 2015 | 4365693 |
| [esophagial varices sclerosing. palliative therapy for hemorrhage in portal hypertension (author's transl)]. | | 1999 | 91474 |
| influence of stimulus-response translations on response programming: examining the relationship of arm, direction, and extent of movement. | | 2014 | 3953307 |
| adenohypophyseal function during cerebral angiography. | | 2015 | 4372654 |
| writing for publication. | | 2013 | 3646047 |
| craniofacial osteotomies to facilitate skull base tumour resection. | in order to expose deeply situated tumours of the skull base in various regions, the concept of osteotomies of segments of the facial skeleton has been developed. the portion of skeleton overlying the tumour is removed, the lesion is resected and the removed bony structure is then reinserted. this has greatly facilitated tumour removal in difficult areas. the advantages of this approach are, to the surgeon, total en bloc resection of deeply situated tumours with few complications; for the patien ... | 2013 | 3697557 |
| focal nodular hyperplasia of the liver and oral contraceptives. | the increased incidence of liver tumors in women of childbearing age who have been using oral contraceptives for many years suggests an environmental causation. the causative agent may be the steroidal oral contraceptives. two lesions are recognized: focal nodular hyperplasia and hepatic adenoma. this paper concentrates on focal nodular hyperplasia, with two cases added to the four previously described cases. it is postulated that the estrogen component causes vascular lesions characterized by m ... | 1987 | 213973 |
| nicotine gum in smoking cessation: rationale, efficacy, and proper use. | | 2013 | 3568597 |